Nivo has launched a new market proposition featuring AI agents for lenders and brokers that work 24/7 over email to gather ...
Wolchok and colleagues presented 6.5-year outcomes in patients with advanced melanoma at ASCO 2021. These data showed remarkably durable benefit of ipilimumab (ipi) and nivolumab (nivo) versus ...
TORONTO, April 20, 2026 /PRNewswire/ - PomeGran Inc. (PomeGran) today announced the launch of NIVO for Business, a new suite of fibre connectivity and communications solutions designed to support ...
Phase I/II study of the oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma (RCC). This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers Symposium.
This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. A fintech company dedicated to improving experiences in financial ...
A phase II study of MOR208 plus idelalisib in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) previously treated with a Bruton's tyrosine ...
The NIVO score predicts in-ICU mortality, 1-year mortality, and NIV failure in AECOPD patients requiring mechanical ventilation. It evaluates six variables at admission, including arterial blood pH ...
With communication being such a large part of a mortgage broker’s duty, anything that makes the process smoother should be welcome. Mortgage Strategy spoke to Michael Common, chief executive and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results